<DOC>
	<DOC>NCT01341392</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetic drug interaction between CKD-501 and amlodipine after oral administration in healthy male volunteers.</brief_summary>
	<brief_title>Drug-drug Interaction Study(CKD-501, Amlodipine)</brief_title>
	<detailed_description>Volunteers doses three times over the period of CKD-501 0.5mg or Amlodipine 10mg alone/co-administrate, repeated doses are 10 days.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Between 20 aged and 45 years old in healthy males Body weight ≥ 55kg and 18.5 ≤ IBW &lt; 25 Agreement with written informed consent Subject has a history affects the ADME of drug Hypersensitivity reactions to drugs or clinically significant hypersensitivity reactions in the history of party Inadequate subject by medical examination(medical history, physical examination, ECG, laboratory test) AST,ALT &gt; UNL * 1.25 or Total bilirubin &gt; UNL * 1.5 Estimated GFR(MDRD) &lt; 80 SBP &gt;150 mmHg, SBP &lt; 100 mmHg or DBP &gt; 100 mmHg, DBP &lt; 60 mmHg or Pulse &gt; 100 per/min, Pulse &lt; 50 per/min Substance abuse, or a history of drug abuse showed a positive for the party Continued to be taking caffeine (caffeine &gt; 5 cup/day), drinking (alcohol &gt; 210 g/week) or cannot stop drinking or severe heavy smoker(cigarette &gt; 10 cigarettes per day)during clinical trials Medication with drugmediated induction/inhibition metabolic enzyme within 30 days or with may affect the clinical trial Medication within 2 weeks in the first professional medical, medicine, OTC, vitamins taking Subject takes grapefruit within 1 month Previously participated in other trial within 60 days Previously donate whole blood within 60 days or component blood within 30 days An impossible one who participates in clinical trial by investigator's decision including laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Drug-Drug interaction between the CKD-501 and Amlodipine</keyword>
</DOC>